The market has given the Azek acquisition the thumbs down for now, but James Hardie management sees ...
The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback